Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07227311 |
| Title | A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | RECRUITING | Fort Myers | Florida | 33912 | United States | Details |
| GSK Investigational Site | RECRUITING | Macon | Georgia | 31210 | United States | Details |
| GSK Investigational Site | RECRUITING | Bethesda | Maryland | 20817 | United States | Details |
| GSK Investigational Site | RECRUITING | Springfield | Missouri | 65807 | United States | Details |
| GSK Investigational Site | RECRUITING | Farmington | New Mexico | 87401 | United States | Details |
| GSK Investigational Site | RECRUITING | Ehime | 790-8524 | Japan | Details |